WALDEMARPRIEBEWALDEMAR PRIEBE8492PRIEBE, WALDEMARProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25465288Kong LY, Wei J, Haider AS, Liebelt BD, Ling X, Conrad CA, Fuller GN, Levine NB, Priebe W, Sawaya R, Heimberger ABJournal of neuroimmunologyTherapeutic targets in subependymoma. J Neuroimmunol. 2014 Dec 15; 277(1-2):168-75.J Neuroimmunol2014-10-31T00:00:002014Therapeutic targets in subependymoma.1901 East RoadHouston77054-3005TXAuthorship 1635812Authorship 1636012Authorship 1641321Authorship 1644302Authorship 1653144Authorship 1656272Authorship 1656313Authorship 1665024Authorship 1672619Authorship 1693752Authorship 1747225Authorship 1751953Authorship 1761771Authorship 1767008Authorship 1768473Authorship 1775856Authorship 17804012Authorship 1780903Authorship 17909110Authorship 1791467Authorship 1798767Authorship 18056813Authorship 1807532Authorship 18157410Authorship 1821189Authorship 1828232Authorship 18338612Authorship 18343813Authorship 18380617Authorship 1846259Authorship 1847245Authorship 1848155Authorship 18515110Authorship 1856635Authorship 18604812Authorship 1878198Authorship 1879821Authorship 1886025Authorship 18870117Authorship 1893688Authorship 1898469Authorship 18994114Authorship 19108911Authorship 1950248Authorship 195826112080980Horton D, Priebe W, Carter JP, Filppi J, Wolgemuth RLDrug design and delivery4-Demethoxy-3'-N-trifluoroacetyldoxorubicin. Synthesis and solid tumor activity. Drug Des Deliv. 1990 Jun; 6(2):123-9.Drug Des Deliv1990-06-01T00:00:0019904-Demethoxy-3'-N-trifluoroacetyldoxorubicin. Synthesis and solid tumor activity.2194651Perez-Soler R, Priebe WCancer researchAnthracycline antibiotics with high liposome entrapment: structural features and biological activity. Cancer Res. 1990 Jul 15; 50(14):4260-6.Cancer Res1990-07-15T00:00:001990Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.2387778Priebe W, Neamati N, Perez-Soler RThe Journal of antibiotics3'-Hydroxyesorubicin. Synthesis and antitumor activity. J Antibiot (Tokyo). 1990 Jul; 43(7):838-46.J Antibiot (Tokyo)1990-07-01T00:00:0019903'-Hydroxyesorubicin. Synthesis and antitumor activity.7260960Horton D, Priebe W, Turner WRCarbohydrate researchSynthesis and antitumor activity of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone. Carbohydr Res. 1981 Jul 16; 94(1):11-25.Carbohydr Res1981-07-16T00:00:001981Synthesis and antitumor activity of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone.7805856Borrel MN, Fiallo M, Priebe W, Garnier-Suillerot AFEBS lettersP-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells. FEBS Lett. 1994 Dec 19; 356(2-3):287-99.FEBS Lett1994-12-19T00:00:001994P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells.8194162Perez-Soler R, Ling YH, Zou Y, Priebe WCancer chemotherapy and pharmacologyCellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells. Cancer Chemother Pharmacol. 1994; 34(2):109-18.Cancer Chemother Pharmacol1994-01-01T00:00:001994Cellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells.8370034Horton D, Issa M, Priebe W, Sznaidman MLCarbohydrate researchSynthesis of 3-deoxyaldulosonic acid esters by one-carbon chain extension of glycal-derived lactone precursors. Carbohydr Res. 1993 Aug 17; 246:105-18.Carbohydr Res1993-08-17T00:00:001993Synthesis of 3-deoxyaldulosonic acid esters by one-carbon chain extension of glycal-derived lactone precursors.9054575Lampidis TJ, Kolonias D, Podona T, Israel M, Safa AR, Lothstein L, Savaraj N, Tapiero H, Priebe WBiochemistryCircumvention of P-GP MDR as a function of anthracycline lipophilicity and charge. Biochemistry. 1997 Mar 04; 36(9):2679-85.Biochemistry1997-03-04T00:00:001997Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge.9166763Hu GG, Shui X, Leng F, Priebe W, Chaires JB, Williams LDBiochemistryStructure of a DNA-bisdaunomycin complex. Biochemistry. 1997 May 20; 36(20):5940-6.Biochemistry1997-05-20T00:00:001997Structure of a DNA-bisdaunomycin complex.11020450Marbeuf-Gueye C, Priebe W, Garnier-Suillerot ABiochemical pharmacologyMultidrug resistance protein functionality: no effect of intracellular or extracellular pH changes. Biochem Pharmacol. 2000 Nov 15; 60(10):1485-9.Biochem Pharmacol2000-11-15T00:00:002000Multidrug resistance protein functionality: no effect of intracellular or extracellular pH changes.15909928Marczewska J, Anuszewska EL, Priebe WActa poloniae pharmaceuticaThe application of the sister chromatid exchange test for evaluation of the novel anthracycline derivatives. Part I. Acta Pol Pharm. 2004 Dec; 61 Suppl:22-4.Acta Pol Pharm2004-12-01T00:00:002004The application of the sister chromatid exchange test for evaluation of the novel anthracycline derivatives. Part I.16735036Mansilla S, Priebe W, Portugal JEuropean journal of pharmacologyTranscriptional changes facilitate mitotic catastrophe in tumour cells that contain functional p53. Eur J Pharmacol. 2006 Jul 01; 540(1-3):34-45.Eur J Pharmacol2006-04-30T00:00:002006Transcriptional changes facilitate mitotic catastrophe in tumour cells that contain functional p53.17072745Brooks TA, O'Loughlin KL, Minderman H, Bundy BN, Ford LA, Vredenburg MR, Bernacki RJ, Priebe W, Baer MRInvestigational new drugsThe 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells. Invest New Drugs. 2007 Apr; 25(2):115-22.Invest New Drugs2006-10-28T00:00:002006The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells.17161827Bidwell GL, Fokt I, Priebe W, Raucher DBiochemical pharmacologyDevelopment of elastin-like polypeptide for thermally targeted delivery of doxorubicin. Biochem Pharmacol. 2007 Mar 01; 73(5):620-31.Biochem Pharmacol2006-11-10T00:00:002006Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.17217917Mansilla S, Rojas M, Bataller M, Priebe W, Portugal JBiochemical pharmacologyCircumvention of the multidrug-resistance protein (MRP-1) by an antitumor drug through specific inhibition of gene transcription in breast tumor cells. Biochem Pharmacol. 2007 Apr 01; 73(7):934-42.Biochem Pharmacol2006-12-10T00:00:002006Circumvention of the multidrug-resistance protein (MRP-1) by an antitumor drug through specific inhibition of gene transcription in breast tumor cells.17557149Gruber BM, Anuszewska EL, Bubko I, Gozdzik A, Fokt I, Priebe WArchivum immunologiae et therapiae experimentalisEffect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells. Arch Immunol Ther Exp (Warsz). 2007 May-Jun; 55(3):193-8.Arch Immunol Ther Exp (Warsz)2007-06-08T00:00:002007Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells.18056455Ferrajoli A, Faderl S, Van Q, Koch P, Harris D, Liu Z, Hazan-Halevy I, Wang Y, Kantarjian HM, Priebe W, Estrov ZCancer researchWP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells. Cancer Res. 2007 Dec 01; 67(23):11291-9.Cancer Res2007-12-01T00:00:002007WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.18245540Verstovsek S, Manshouri T, Quint?s-Cardama A, Harris D, Cortes J, Giles FJ, Kantarjian H, Priebe W, Estrov ZClinical cancer research : an official journal of the American Association for Cancer ResearchWP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation. Clin Cancer Res. 2008 Feb 01; 14(3):788-96.Clin Cancer Res2008-02-01T00:00:002008WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation.19350687Gao H, Priebe W, Glod J, Banerjee DStem cells (Dayton, Ohio)Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells. 2009 Apr; 27(4):857-65.Stem Cells2009-04-01T00:00:002009Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium.21684359Mansilla S, Priebe W, Portugal JBiochimica et biophysica actaChanges in gene expression induced by Sp1 knockdown differ from those caused by challenging Sp1 binding to gene promoters. Biochim Biophys Acta. 2011 Jul; 1809(7):327-36.Biochim Biophys Acta2011-06-13T00:00:002011Changes in gene expression induced by Sp1 knockdown differ from those caused by challenging Sp1 binding to gene promoters.21907928Atkinson JM, Shelat AA, Carcaboso AM, Kranenburg TA, Arnold LA, Boulos N, Wright K, Johnson RA, Poppleton H, Mohankumar KM, F?au C, Phoenix T, Gibson P, Zhu L, Tong Y, Eden C, Ellison DW, Priebe W, Koul D, Yung WK, Gajjar A, Stewart CF, Guy RK, Gilbertson RJCancer cellAn integrated in?vitro and in?vivo high-throughput screen identifies treatment leads for ependymoma. Cancer Cell. 2011 Sep 13; 20(3):384-99.Cancer Cell2011-09-13T00:00:002011An integrated in?vitro and in?vivo high-throughput screen identifies treatment leads for ependymoma.23523885Mielecki M, Krawiec K, Kiburu I, Grzelak K, Zag?rski W, Kierdaszuk B, Kowa K, Fokt I, Szymanski S, Swierk P, Szeja W, Priebe W, Lesyng B, LaRonde-LeBlanc NBiochimica et biophysica actaDevelopment of novel molecular probes of the Rio1 atypical protein kinase. Biochim Biophys Acta. 2013 Jul; 1834(7):1292-301.Biochim Biophys Acta2013-03-20T00:00:002013Development of novel molecular probes of the Rio1 atypical protein kinase.Cancer Systems ImagingExperimental TherapeuticsGynecological Oncology & Reproductive MedicineHead & Neck SurgeryLeukemiaMolecular & Cellular OncologyMD AndersonMIEN-CHIEHUNGMIEN-CHIE HUNG8427HUNG, MIEN-CHIEProfessorRAYMOND ESAWAYARAYMOND E SAWAYA8456SAWAYA, RAYMOND EProfessorJORGE ECORTESJORGE E CORTES8637CORTES, JORGE EProfessorMICHAEL ELLIOTKUPFERMANMICHAEL ELLIOT KUPFERMAN9170KUPFERMAN, MICHAEL ELLIOTAssociate ProfessorMICHAELANDREEFFMICHAEL ANDREEFF8437ANDREEFF, MICHAELProfessor3.466980.00432636688research areas3.541340.009032369coauthor of85.732914.048160similar to11231selected publicationsHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorAMY BHEIMBERGERAMY B HEIMBERGER9035HEIMBERGER, AMY BProfessorIZABELAFOKTIZABELA FOKT8627FOKT, IZABELAInstructorANIL KSOODANIL K SOOD9048SOOD, ANIL KProfessorFLORIANMULLERFLORIAN MULLER9794MULLER, FLORIANAssistant ProfessorAuthorship 2120802Authorship 2127902Authorship 2131792Authorship 2135082Authorship 2139112Authorship 2139512Authorship 2150074Authorship 2151804Authorship 2152122Authorship 2154384Authorship 2163952Authorship 2164822Authorship 2167602Authorship 2171262Authorship 2180431Authorship 2187672Authorship 2199436Authorship 2202105Authorship 2206297Authorship 2214744Authorship 22265412Authorship 2226895Authorship 2242945Authorship 2249262Authorship 2260663Authorship 2263682Authorship 2334206Authorship 23359651643693Perez-Soler R, Priebe WCancer chemotherapy and pharmacologyLiposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicin. Cancer Chemother Pharmacol. 1992; 30(4):267-71.Cancer Chemother Pharmacol1992-01-01T00:00:001992Liposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicin.3242811Horton D, Priebe W, Sznaidman MCarbohydrate researchPreparative procedures for conversion of daunorubicin into doxorubicin (Adriamycin) and 14-O-acetyldoxorubicin by way of 14-bromodaunorubicin. Carbohydr Res. 1988 Dec 31; 184:231-5.Carbohydr Res1988-12-31T00:00:001988Preparative procedures for conversion of daunorubicin into doxorubicin (Adriamycin) and 14-O-acetyldoxorubicin by way of 14-bromodaunorubicin.4092209Horton D, Priebe W, Varela OCarbohydrate researchSynthesis and antitumor activity of 2'-bromo- and 2'-chloro-3'-acetoxy-3'-deaminodaunorubicin analogs. Carbohydr Res. 1985 Dec 01; 144(2):305-15.Carbohydr Res1985-12-01T00:00:001985Synthesis and antitumor activity of 2'-bromo- and 2'-chloro-3'-acetoxy-3'-deaminodaunorubicin analogs.4092211Horton D, Priebe W, Varela OCarbohydrate researchSelective silylation of 6-deoxyglycals. Carbohydr Res. 1985 Dec 01; 144(2):325-30.Carbohydr Res1985-12-01T00:00:001985Selective silylation of 6-deoxyglycals.6548219Horton D, Priebe W, Varela OThe Journal of antibioticsSynthesis and antitumor activity of 3'-deamino-3'-hydroxydoxorubicin. A facile procedure for the preparation of doxorubicin analogs. J Antibiot (Tokyo). 1984 Aug; 37(8):853-8.J Antibiot (Tokyo)1984-08-01T00:00:001984Synthesis and antitumor activity of 3'-deamino-3'-hydroxydoxorubicin. A facile procedure for the preparation of doxorubicin analogs.6549317Horton D, Priebe W, Varela OThe Journal of antibiotics3'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity. J Antibiot (Tokyo). 1984 Dec; 37(12):1635-41.J Antibiot (Tokyo)1984-12-01T00:00:0019843'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity.7531410Zhao JY, Savaraj N, Song R, Priebe W, Kuo MTAnticancer researchOverexpression of P-glycoprotein but not its mRNA in multidrug resistant cells selected with hydroxyrubicin. Anticancer Res. 1994 Sep-Oct; 14(5A):1735-42.Anticancer Res1994-09-01T00:00:001994Overexpression of P-glycoprotein but not its mRNA in multidrug resistant cells selected with hydroxyrubicin.7768640Zou Y, Ling YH, Reddy S, Priebe W, Perez-Soler RInternational journal of cancerEffect of vesicle size and lipid composition on the in vivo tumor selectivity and toxicity of the non-cross-resistant anthracycline annamycin incorporated in liposomes. Int J Cancer. 1995 May 29; 61(5):666-71.Int J Cancer1995-05-29T00:00:001995Effect of vesicle size and lipid composition on the in vivo tumor selectivity and toxicity of the non-cross-resistant anthracycline annamycin incorporated in liposomes.8137251Zou Y, Ling YH, Van NT, Priebe W, Perez-Soler RCancer researchAntitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties. Cancer Res. 1994 Mar 15; 54(6):1479-84.Cancer Res1994-03-15T00:00:001994Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.8270495Horton D, Priebe W, Sznaidman ML, Varela OThe Journal of antibioticsSynthesis and antitumor activity of anthracycline disaccharide glycosides containing daunosamine. J Antibiot (Tokyo). 1993 Nov; 46(11):1720-30.J Antibiot (Tokyo)1993-11-01T00:00:001993Synthesis and antitumor activity of anthracycline disaccharide glycosides containing daunosamine.8453627Ling YH, Priebe W, Yang LY, Burke TG, Pommier Y, Perez-Soler RCancer researchIn vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes. Cancer Res. 1993 Apr 01; 53(7):1583-9.Cancer Res1993-04-01T00:00:001993In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.8995506Zou Y, Priebe W, Perez-Soler RCancer chemotherapy and pharmacologyLyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size. Cancer Chemother Pharmacol. 1996; 39(1-2):103-8.Cancer Chemother Pharmacol1996-01-01T00:00:001996Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size.9289011Robinson H, Priebe W, Chaires JB, Wang AHBiochemistryBinding of two novel bisdaunorubicins to DNA studied by NMR spectroscopy. Biochemistry. 1997 Jul 22; 36(29):8663-70.Biochemistry1997-07-22T00:00:001997Binding of two novel bisdaunorubicins to DNA studied by NMR spectroscopy.9815933Zou Y, Priebe W, Stephens LC, Perez-Soler RClinical cancer research : an official journal of the American Association for Cancer ResearchPreclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity. Clin Cancer Res. 1995 Nov; 1(11):1369-74.Clin Cancer Res1995-11-01T00:00:001995Preclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity.11172688Pratesi G, Monestiroli SVCurrent medicinal chemistryPreclinical evaluation of new anthracyclines. Curr Med Chem. 2001 Jan; 8(1):9-13.Curr Med Chem2001-01-01T00:00:002001Preclinical evaluation of new anthracyclines.11585053Loetchutinat C, Heywang C, Priebe W, Garnier-Suillerot ABiochemical pharmacologyThe absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin. Biochem Pharmacol. 2001 Sep 01; 62(5):561-7.Biochem Pharmacol2001-09-01T00:00:002001The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin.12111105Booser DJ, Esteva FJ, Rivera E, Valero V, Esparza-Guerra L, Priebe W, Hortobagyi GNCancer chemotherapy and pharmacologyPhase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer. Cancer Chemother Pharmacol. 2002 Jul; 50(1):6-8.Cancer Chemother Pharmacol2002-05-21T00:00:002002Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.12932909Fuks L, Samochocka K, Anulewicz-Ostrowska R, Kruszewski M, Priebe W, Lewandowski WEuropean journal of medicinal chemistryStructure and biological activity of cationic [PtLCl(DMSO)]NO(3).DMSO complex containing a chelated diaminosugar: methyl-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxopyranoside. Eur J Med Chem. 2003 Jul-Aug; 38(7-8):775-80.Eur J Med Chem2003-07-01T00:00:002003Structure and biological activity of cationic [PtLCl(DMSO)]NO(3).DMSO complex containing a chelated diaminosugar: methyl-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxopyranoside.15105117Kutsch O, Levy DN, Bates PJ, Decker J, Kosloff BR, Shaw GM, Priebe W, Benveniste ENAntimicrobial agents and chemotherapyBis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription. Antimicrob Agents Chemother. 2004 May; 48(5):1652-63.Antimicrob Agents Chemother2004-05-01T00:00:002004Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription.15542779Trevino AV, Woynarowska BA, Herman TS, Priebe W, Woynarowski JMMolecular cancer therapeuticsEnhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues. Mol Cancer Ther. 2004 Nov; 3(11):1403-10.Mol Cancer Ther2004-11-01T00:00:002004Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues.16161349Chlopkiewicz B, Ejchart A, Marczewska J, Anuszewska E, Priebe WActa poloniae pharmaceuticaEvaluation of mutagenic and genotoxic activities of new derivatives of anthracyclines. Acta Pol Pharm. 2005 Mar-Apr; 62(2):99-104.Acta Pol Pharm2005-03-01T00:00:002005Evaluation of mutagenic and genotoxic activities of new derivatives of anthracyclines.16555088Lampidis TJ, Kurtoglu M, Maher JC, Liu H, Krishan A, Sheft V, Szymanski S, Fokt I, Rudnicki WR, Ginalski K, Lesyng B, Priebe WCancer chemotherapy and pharmacologyEfficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells". Cancer Chemother Pharmacol. 2006 Dec; 58(6):725-34.Cancer Chemother Pharmacol2006-03-23T00:00:002006Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".17195067Zheng M, Priebe W, Walch ET, Roth KG, Han M, Tang CH, Lee S, Poindexter NJ, Fokt I, Grimm EACancer chemotherapy and pharmacologyWP760, a melanoma selective drug. Cancer Chemother Pharmacol. 2007 Oct; 60(5):625-33.Cancer Chemother Pharmacol2006-12-29T00:00:002006WP760, a melanoma selective drug.17515324Gruber BM, Anuszewska EL, Roman I, Gozdzik A, Priebe W, Fokt IActa poloniae pharmaceuticaTopoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cells. Acta Pol Pharm. 2006 Jan-Feb; 63(1):15-8.Acta Pol Pharm2006-01-01T00:00:002006Topoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cells.18713952van Schalkwyk DA, Priebe W, Saliba KJThe Journal of pharmacology and experimental therapeuticsThe inhibitory effect of 2-halo derivatives of D-glucose on glycolysis and on the proliferation of the human malaria parasite Plasmodium falciparum. J Pharmacol Exp Ther. 2008 Nov; 327(2):511-7.J Pharmacol Exp Ther2008-08-19T00:00:002008The inhibitory effect of 2-halo derivatives of D-glucose on glycolysis and on the proliferation of the human malaria parasite Plasmodium falciparum.19055400Korchowiec J, Korchowiec B, Priebe W, Rogalska EThe journal of physical chemistry. ADFT study on the selectivity of complexation of metal cations with a dioxadithia crown ether ligand. J Phys Chem A. 2008 Dec 25; 112(51):13633-40.J Phys Chem A2008-12-25T00:00:002008DFT study on the selectivity of complexation of metal cations with a dioxadithia crown ether ligand.23376241Fokt I, Skora S, Conrad C, Madden T, Emmett M, Priebe WCarbohydrate researchD-Glucose and D-mannose-based metabolic probes. Part 3: Synthesis of specifically deuterated D-glucose, D-mannose, and 2-deoxy-D-glucose. Carbohydr Res. 2013 Mar 07; 368:111-9.Carbohydr Res2012-12-13T00:00:002012D-Glucose and D-mannose-based metabolic probes. Part 3: Synthesis of specifically deuterated D-glucose, D-mannose, and 2-deoxy-D-glucose.23800968Emmett MR, Kroes RA, Moskal JR, Conrad CA, Priebe W, Laezza F, Meyer-Baese A, Nilsson CLNeuropsychopharmacology : official publication of the American College of NeuropsychopharmacologyIntegrative biological analysis for neuropsychopharmacology. Neuropsychopharmacology. 2014 Jan; 39(1):5-23.Neuropsychopharmacology2013-06-26T00:00:002013Integrative biological analysis for neuropsychopharmacology.Authorship 2370042Authorship 2377903Authorship 2378022Authorship 2378542Authorship 238787Authorship 2388833Authorship 2394217Authorship 2397773Authorship 2399152Authorship 2400802Authorship 2401396Authorship 2402454Authorship 2402461Authorship 2402583Authorship 2411462Authorship 2412784Authorship 2413651Authorship 2419082Authorship 2420514Authorship 2422443Authorship 2424224Authorship 2425034Authorship 2425277Authorship 24312410Authorship 2433404Authorship 2434373Authorship 2437671Authorship 2438718Authorship 2445632Authorship 2449113Authorship 2452793Authorship 2455294Authorship 2456733Authorship 2462582Authorship 2466894Authorship 2467935Authorship 2469977Authorship 2485091Authorship 2485246Authorship 2488465Authorship 2498064Authorship 2499247Authorship 2511787Authorship 2511826Authorship 2553148Authorship 25759412Authorship 26262522752389Horton D, Priebe W, Sznaidman MCarbohydrate researchA new approach to 2-deoxyglycosides permitting access to anthracycline glycosides specifically labeled at the 2'-position. Carbohydr Res. 1989 Apr 01; 187(1):149-53.Carbohydr Res1989-04-01T00:00:001989A new approach to 2-deoxyglycosides permitting access to anthracycline glycosides specifically labeled at the 2'-position.4019314Cheung TM, Horton D, Priebe W, Turner WR, Weckerle WThe Journal of antibioticsSugar-ring analogs of daunorubicin: 3'-epidaunorubicin, 3'-hydroxy-3',5'-diepidaunorubicin and 3',6'-dihydroxy-3',5'-diepidaunorubicin. J Antibiot (Tokyo). 1985 May; 38(5):683-6.J Antibiot (Tokyo)1985-05-01T00:00:001985Sugar-ring analogs of daunorubicin: 3'-epidaunorubicin, 3'-hydroxy-3',5'-diepidaunorubicin and 3',6'-dihydroxy-3',5'-diepidaunorubicin.4092212Bhat? P, Horton D, Priebe WCarbohydrate researchAllylic rearrangement of 6-deoxyglycals having practical utility. Carbohydr Res. 1985 Dec 01; 144(2):331-7.Carbohydr Res1985-12-01T00:00:001985Allylic rearrangement of 6-deoxyglycals having practical utility.7319917Horton D, Priebe WThe Journal of antibioticsNew adriamycin analogs. Synthesis and antitumor activity of 14-substituted 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)daunomycinones. J Antibiot (Tokyo). 1981 Aug; 34(8):1019-25.J Antibiot (Tokyo)1981-08-01T00:00:001981New adriamycin analogs. Synthesis and antitumor activity of 14-substituted 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)daunomycinones.7729954Ling YH, Zou Y, Priebe W, Perez-Soler RInternational journal of cancerPartial circumvention of multi-drug resistance by annamycin is associated with comparable inhibition of DNA synthesis in the nuclear matrix of sensitive and resistant cells. Int J Cancer. 1995 May 04; 61(3):402-8.Int J Cancer1995-05-04T00:00:001995Partial circumvention of multi-drug resistance by annamycin is associated with comparable inhibition of DNA synthesis in the nuclear matrix of sensitive and resistant cells.7907237Lothstein L, Hosey LM, Sweatman TW, Koseki Y, Dockter M, Priebe WOncology researchN-benzyladriamycin-14-valerate (AD 198)-resistant cells exhibit highly selective cross-resistance to other anthracyclines that circumvent multidrug resistance. Oncol Res. 1993; 5(6-7):229-34.Oncol Res1993-01-01T00:00:001993N-benzyladriamycin-14-valerate (AD 198)-resistant cells exhibit highly selective cross-resistance to other anthracyclines that circumvent multidrug resistance.8014019Solary E, Ling YH, Perez-Soler R, Priebe W, Pommier YInternational journal of cancerHydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance. Int J Cancer. 1994 Jul 01; 58(1):85-94.Int J Cancer1994-07-01T00:00:001994Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance.8022858Priebe W, Perez-Soler RPharmacology & therapeuticsDesign and tumor targeting of anthracyclines able to overcome multidrug resistance: a double-advantage approach. Pharmacol Ther. 1993 Nov; 60(2):215-34.Pharmacol Ther1993-11-01T00:00:001993Design and tumor targeting of anthracyclines able to overcome multidrug resistance: a double-advantage approach.8500223Zou Y, Priebe W, Ling YH, Perez-Soler RCancer chemotherapy and pharmacologyOrgan distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles. Cancer Chemother Pharmacol. 1993; 32(3):190-6.Cancer Chemother Pharmacol1993-01-01T00:00:001993Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles.8618244Broxterman HJ, Heijn M, Lankelma JJournal of the National Cancer InstituteRe: How does the MRP/GS-X pump export doxorubicin? J Natl Cancer Inst. 1996 Apr 03; 88(7):466-8.J Natl Cancer Inst1996-04-03T00:00:001996Re: How does the MRP/GS-X pump export doxorubicin?8646789Joll?s B, Laigle A, Priebe W, Garnier-Suillerot AChemico-biological interactionsComparison of DNA sequence selectivity of anthracycline antibiotics and their 3'-hydroxylated analogs. Chem Biol Interact. 1996 Mar 25; 100(2):165-76.Chem Biol Interact1996-03-25T00:00:001996Comparison of DNA sequence selectivity of anthracycline antibiotics and their 3'-hydroxylated analogs.8944778Gallois L, Fiallo M, Laigle A, Priebe W, Garnier-Suillerot AEuropean journal of biochemistryThe overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids. Eur J Biochem. 1996 Nov 01; 241(3):879-87.Eur J Biochem1996-11-01T00:00:001996The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids.9096663Perez-Soler R, Neamati N, Zou Y, Schneider E, Doyle LA, Andreeff M, Priebe W, Ling YHInternational journal of cancerAnnamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide. Int J Cancer. 1997 Mar 28; 71(1):35-41.Int J Cancer1997-03-28T00:00:001997Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide.9485299Leng F, Priebe W, Chaires JBBiochemistryUltratight DNA binding of a new bisintercalating anthracycline antibiotic. Biochemistry. 1998 Feb 17; 37(7):1743-53.Biochemistry1998-02-17T00:00:001998Ultratight DNA binding of a new bisintercalating anthracycline antibiotic.9611247Dutta R, Gao YG, Priebe W, Wang AHNucleic acids researchBinding of the modified daunorubicin WP401 adjacent to a T-G base pair induces the reverse Watson-Crick conformation: crystal structures of the WP401-TGGCCG and WP401-CGG[br5C]CG complexes. Nucleic Acids Res. 1998 Jun 15; 26(12):3001-5.Nucleic Acids Res1998-06-15T00:00:001998Binding of the modified daunorubicin WP401 adjacent to a T-G base pair induces the reverse Watson-Crick conformation: crystal structures of the WP401-TGGCCG and WP401-CGG[br5C]CG complexes.9647783Priebe W, Krawczyk M, Kuo MT, Yamane Y, Savaraj N, Ishikawa TBiochemical and biophysical research communicationsDoxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump. Biochem Biophys Res Commun. 1998 Jun 29; 247(3):859-63.Biochem Biophys Res Commun1998-06-29T00:00:001998Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump.10335267Tarasiuk J, Tkaczyk-Gobis K, Stefa?ska B, Dzieduszycka M, Priebe W, Martelli S, Borowski EAnti-cancer drug designThe role of structural factors of anthraquinone compounds and their quinone-modified analogues in NADH dehydrogenase-catalysed oxygen radical formation. Anticancer Drug Des. 1998 Dec; 13(8):923-39.Anticancer Drug Des1998-12-01T00:00:001998The role of structural factors of anthraquinone compounds and their quinone-modified analogues in NADH dehydrogenase-catalysed oxygen radical formation.10395948Marbeuf-Gueye C, Ettori D, Priebe W, Kozlowski H, Garnier-Suillerot ABiochimica et biophysica actaCorrelation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein. Biochim Biophys Acta. 1999 Jul 08; 1450(3):374-84.Biochim Biophys Acta1999-07-08T00:00:001999Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein.10446226Mart?n B, Vaquero A, Priebe W, Portugal JNucleic acids researchBisanthracycline WP631 inhibits basal and Sp1-activated transcription initiation in vitro. Nucleic Acids Res. 1999 Sep 01; 27(17):3402-9.Nucleic Acids Res1999-09-01T00:00:001999Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiation in vitro.10708754Hooijberg JH, Pinedo HM, Vrasdonk C, Priebe W, Lankelma J, Broxterman HJFEBS lettersThe effect of glutathione on the ATPase activity of MRP1 in its natural membranes. FEBS Lett. 2000 Mar 03; 469(1):47-51.FEBS Lett2000-03-03T00:00:002000The effect of glutathione on the ATPase activity of MRP1 in its natural membranes.10961673Rudnicki WR, Kurzepa M, Szczepanik T, Priebe W, Lesyng BActa biochimica PolonicaA simple model for predicting the free energy of binding between anthracycline antibiotics and DNA. Acta Biochim Pol. 2000; 47(1):1-9.Acta Biochim Pol2000-01-01T00:00:002000A simple model for predicting the free energy of binding between anthracycline antibiotics and DNA.11027298Qu X, Trent JO, Fokt I, Priebe W, Chaires JBProceedings of the National Academy of Sciences of the United States of AmericaAllosteric, chiral-selective drug binding to DNA. Proc Natl Acad Sci U S A. 2000 Oct 24; 97(22):12032-7.Proc Natl Acad Sci U S A2000-10-24T00:00:002000Allosteric, chiral-selective drug binding to DNA.11108806Hu Y, Moraes CT, Savaraj N, Priebe W, Lampidis TJBiochemical pharmacologyRho(0) tumor cells: a model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs. Biochem Pharmacol. 2000 Dec 15; 60(12):1897-905.Biochem Pharmacol2000-12-15T00:00:002000Rho(0) tumor cells: a model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs.11172692Garnier-Suillerot A, Marbeuf-Gueye C, Salerno M, Loetchutinat C, Fokt I, Krawczyk M, Kowalczyk T, Priebe WCurrent medicinal chemistryAnalysis of drug transport kinetics in multidrug-resistant cells: implications for drug action. Curr Med Chem. 2001 Jan; 8(1):51-64.Curr Med Chem2001-01-01T00:00:002001Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action.11331019Liu H, Hu YP, Savaraj N, Priebe W, Lampidis TJBiochemistryHypersensitization of tumor cells to glycolytic inhibitors. Biochemistry. 2001 May 08; 40(18):5542-7.Biochemistry2001-05-08T00:00:002001Hypersensitization of tumor cells to glycolytic inhibitors.11502206Loetchutinat C, Priebe W, Garnier-Suillerot AEuropean journal of biochemistryDrug sequestration in cytoplasmic organelles does not contribute to the diminished sensitivity of anthracyclines in multidrug resistant K562 cells. Eur J Biochem. 2001 Aug; 268(16):4459-67.Eur J Biochem2001-08-01T00:00:002001Drug sequestration in cytoplasmic organelles does not contribute to the diminished sensitivity of anthracyclines in multidrug resistant K562 cells.11911247Faderl S, Estrov Z, Kantarjian HM, Harris D, Van Q, Fokt I, Przewloka T, Godlewski C, Woynarowski JM, Priebe WAnticancer researchWP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity. Anticancer Res. 2001 Nov-Dec; 21(6A):3777-84.Anticancer Res2001-11-01T00:00:002001WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.11996888Salerno M, Przewloka T, Fokt I, Priebe W, Garnier-Suillerot ABiochemical pharmacologyPreferential efflux by P-glycoprotein, but not MRP1, of compounds containing a free electron donor amine. Biochem Pharmacol. 2002 Apr 15; 63(8):1471-9.Biochem Pharmacol2002-04-15T00:00:002002Preferential efflux by P-glycoprotein, but not MRP1, of compounds containing a free electron donor amine.12219017Inge TH, Casson LK, Priebe W, Trent JO, Georgeson KE, Miller DM, Bates PJSurgeryImportance of Sp1 consensus motifs in the MYCN promoter. Surgery. 2002 Aug; 132(2):232-8.Surgery2002-08-01T00:00:002002Importance of Sp1 consensus motifs in the MYCN promoter.12581216Villamar?n S, Mansilla S, Ferrer-Miralles N, Priebe W, Portugal JEuropean journal of biochemistryA comparative analysis of the time-dependent antiproliferative effects of daunorubicin and WP631. Eur J Biochem. 2003 Feb; 270(4):764-70.Eur J Biochem2003-02-01T00:00:002003A comparative analysis of the time-dependent antiproliferative effects of daunorubicin and WP631.12616592Kruszewski M, Bouzyk E, Oldak T, Samochocka K, Fuks L, Lewandowski W, Fokt I, Priebe WTeratogenesis, carcinogenesis, and mutagenesisDifferential toxic effect of cis-platinum(II) and palladium(II) chlorides complexed with methyl 3,4-diamine-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside in mouse lymphoma cell lines differing in DSB and NER repair ability. Teratog Carcinog Mutagen. 2003; Suppl 1:1-11.Teratog Carcinog Mutagen2003-01-01T00:00:002003Differential toxic effect of cis-platinum(II) and palladium(II) chlorides complexed with methyl 3,4-diamine-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside in mouse lymphoma cell lines differing in DSB and NER repair ability.12732461Haj HT, Salerno M, Priebe W, Kozlowski H, Garnier-Suillerot AChemico-biological interactionsNew findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA. Chem Biol Interact. 2003 Jun 15; 145(3):349-58.Chem Biol Interact2003-06-15T00:00:002003New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA.14698047Ashikawa K, Shishodia S, Fokt I, Priebe W, Aggarwal BBBiochemical pharmacologyEvidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues. Biochem Pharmacol. 2004 Jan 15; 67(2):353-64.Biochem Pharmacol2004-01-15T00:00:002004Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues.14729604Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, De Young LR, Lampidis TJCancer research2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res. 2004 Jan 01; 64(1):31-4.Cancer Res2004-01-01T00:00:0020042-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.14750133Pozarowski P, Huang X, Gong RW, Priebe W, Darzynkiewicz ZCytometry. Part A : the journal of the International Society for Analytical CytologySimple, semiautomatic assay of cytostatic and cytotoxic effects of antitumor drugs by laser scanning cytometry: effects of the bis-intercalator WP631 on growth and cell cycle of T-24 cells. Cytometry A. 2004 Feb; 57(2):113-9.Cytometry A2004-02-01T00:00:002004Simple, semiautomatic assay of cytostatic and cytotoxic effects of antitumor drugs by laser scanning cytometry: effects of the bis-intercalator WP631 on growth and cell cycle of T-24 cells.15559760Pawlowska J, Priebe W, Paine MJ, Wolf CR, Borowski E, Tarasiuk JOncology researchThe ability of new sugar-modified derivatives of antitumor anthracycline, daunorubicin, to stimulate NAD(P)H oxidation in different cellular oxidoreductase systems: NADH dehydrogenase, NADPH cytochrome P450 reductase, and xanthine oxidase. Oncol Res. 2004; 14(10):469-74.Oncol Res2004-01-01T00:00:002004The ability of new sugar-modified derivatives of antitumor anthracycline, daunorubicin, to stimulate NAD(P)H oxidation in different cellular oxidoreductase systems: NADH dehydrogenase, NADPH cytochrome P450 reductase, and xanthine oxidase.16022489Gruber BM, Anuszewska EL, Bubko I, Kasprzycka-Guttman T, Misiewicz I, Skupinska K, Priebe W, Fokt IActa poloniae pharmaceuticaConstitutive activation of transcription factor NFkappaB as a possible marker of sensitivity of neoplastic cells to anthracyclines. Acta Pol Pharm. 2005 Jan-Feb; 62(1):17-23.Acta Pol Pharm2005-01-01T00:00:002005Constitutive activation of transcription factor NFkappaB as a possible marker of sensitivity of neoplastic cells to anthracyclines.16158916Faderl S, Ferrajoli A, Harris D, Van Q, Priebe W, Estrov ZAnticancer researchWP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML). Anticancer Res. 2005 May-Jun; 25(3B):1841-50.Anticancer Res2005-05-01T00:00:002005WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML).16319532Mansilla S, Priebe W, Portugal JCell cycle (Georgetown, Tex.)Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms. Cell Cycle. 2006 Jan; 5(1):53-60.Cell Cycle2006-01-21T00:00:002006Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms.16366602Portugal J, Cashman DJ, Trent JO, Ferrer-Miralles N, Przewloka T, Fokt I, Priebe W, Chaires JBJournal of medicinal chemistryA new bisintercalating anthracycline with picomolar DNA binding affinity. J Med Chem. 2005 Dec 29; 48(26):8209-19.J Med Chem2005-12-29T00:00:002005A new bisintercalating anthracycline with picomolar DNA binding affinity.17202319Bartholomeusz GA, Talpaz M, Kapuria V, Kong LY, Wang S, Estrov Z, Priebe W, Wu J, Donato NJBloodActivation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells. Blood. 2007 Apr 15; 109(8):3470-8.Blood2007-01-03T00:00:002007Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells.17203872Anuszewska E, Chlopkiewicz B, Gruber B, Marczewska J, Priebe W, Skurzak HActa poloniae pharmaceuticaEstimation of DNA damage and cytotoxicity of anthracycline analogs in human melanoma cells on early and late passages. Acta Pol Pharm. 2006 Jul-Aug; 63(4):321-4.Acta Pol Pharm2006-07-01T00:00:002006Estimation of DNA damage and cytotoxicity of anthracycline analogs in human melanoma cells on early and late passages.17483874Bidwell GL, Davis AN, Fokt I, Priebe W, Raucher DInvestigational new drugsA thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. Invest New Drugs. 2007 Aug; 25(4):313-26.Invest New Drugs2007-05-05T00:00:002007A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.18688431Bednarek E, Sitkowski J, Kawecki R, Kozerski L, Bocian W, Pazderski L, Priebe WDalton transactions (Cambridge, England : 2003)Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O. Dalton Trans. 2008 Aug 21; (31):4129-37.Dalton Trans2008-07-08T00:00:002008Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O.18698707Corvis Y, Korchowiec B, Korchowiec J, Badis M, Mironiuk-Puchalska E, Fokt I, Priebe W, Rogalska EThe journal of physical chemistry. BComplexation of metal ions in Langmuir films formed with two amphiphilic dioxadithia crown ethers. J Phys Chem B. 2008 Sep 04; 112(35):10953-63.J Phys Chem B2008-08-12T00:00:002008Complexation of metal ions in Langmuir films formed with two amphiphilic dioxadithia crown ethers.21340606Ahmed AA, Goldsmith J, Fokt I, Le XF, Krzysko KA, Lesyng B, Bast RC, Priebe WCancer chemotherapy and pharmacologyA genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer. Cancer Chemother Pharmacol. 2011 Oct; 68(4):1033-44.Cancer Chemother Pharmacol2011-02-22T00:00:002011A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer.21935404Yan H, Chen X, Zhang Q, Qin J, Li H, Liu C, Calhoun-Davis T, Coletta LD, Klostergaard J, Fokt I, Skora S, Priebe W, Bi Y, Tang DGPloS oneDrug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms. PLoS One. 2011; 6(9):e24397.PLoS One2011-09-15T00:00:002011Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms.25881542Lee HT, Xue J, Chou PC, Zhou A, Yang P, Conrad CA, Aldape KD, Priebe W, Patterson C, Sawaya R, Xie K, Huang SOncotargetStat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells. Oncotarget. 2015 Apr 30; 6(12):10016-29.Oncotarget2015-04-30T00:00:002015Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells.Authorship 2634001Authorship 2634582Authorship 2636783Authorship 2637066Authorship 2637222Authorship 2638903Authorship 2639343Authorship 2640217Authorship 264891Authorship 2649807Authorship 2655731Authorship 2660015Authorship 2660241Authorship 2664583Authorship 2667815Authorship 2672045Authorship 2675676Authorship 2676367Authorship 2683626Authorship 2688692Authorship 2688752Authorship 2694347Authorship 2722314Authorship 27248411577666Priebe W, Neamati N, Perez-soler RThe Journal of antibiotics3'-Hydroxyesorubicin halogenated at C-2'. J Antibiot (Tokyo). 1992 Mar; 45(3):386-93.J Antibiot (Tokyo)1992-03-01T00:00:0019923'-Hydroxyesorubicin halogenated at C-2'.4005892Horton D, Priebe WCarbohydrate researchOxyhalogenation of glycals for the synthesis of anti-tumor-active 2'-halo daunorubicin analogs. Carbohydr Res. 1985 Feb 28; 136:391-6.Carbohydr Res1985-02-28T00:00:001985Oxyhalogenation of glycals for the synthesis of anti-tumor-active 2'-halo daunorubicin analogs.4092210Horton D, Priebe W, Varela OCarbohydrate researchSelective acylation of 6-deoxyglycals. Carbohydr Res. 1985 Dec 01; 144(2):317-24.Carbohydr Res1985-12-01T00:00:001985Selective acylation of 6-deoxyglycals.6630080Horton D, Priebe WThe Journal of antibiotics14-esters of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone: synthesis and antitumor activity. J Antibiot (Tokyo). 1983 Sep; 36(9):1211-5.J Antibiot (Tokyo)1983-09-01T00:00:00198314-esters of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone: synthesis and antitumor activity.7563208Ishikawa T, Akimaru K, Kuo MT, Priebe W, Suzuki MJournal of the National Cancer InstituteHow does the MRP/GS-X pump export doxorubicin? J Natl Cancer Inst. 1995 Nov 01; 87(21):1639-40.J Natl Cancer Inst1995-11-01T00:00:001995How does the MRP/GS-X pump export doxorubicin?8289131Zou Y, Hayman A, Priebe W, Perez-Soler RJournal of pharmaceutical sciencesQuantitative analysis of the lipophilic doxorubicin analogue annamycin in plasma and tissue samples by reversed-phase chromatography. J Pharm Sci. 1993 Nov; 82(11):1151-4.J Pharm Sci1993-11-01T00:00:001993Quantitative analysis of the lipophilic doxorubicin analogue annamycin in plasma and tissue samples by reversed-phase chromatography.8457713Priebe W, Van NT, Burke TG, Perez-Soler RAnti-cancer drugsRemoval of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity. Anticancer Drugs. 1993 Feb; 4(1):37-48.Anticancer Drugs1993-02-01T00:00:001993Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity.8622633Ling YH, el-Naggar AK, Priebe W, Perez-Soler RMolecular pharmacologyCell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol Pharmacol. 1996 May; 49(5):832-41.Mol Pharmacol1996-05-01T00:00:001996Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.8652545Chaires JB, Satyanarayana S, Suh D, Fokt I, Przewloka T, Priebe WBiochemistryParsing the free energy of anthracycline antibiotic binding to DNA. Biochemistry. 1996 Feb 20; 35(7):2047-53.Biochemistry1996-02-20T00:00:001996Parsing the free energy of anthracycline antibiotic binding to DNA.8695811Consoli U, Priebe W, Ling YH, Mahadevia R, Griffin M, Zhao S, Perez-Soler R, Andreeff MBloodThe novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines. Blood. 1996 Jul 15; 88(2):633-44.Blood1996-07-15T00:00:001996The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.9022792Chaires JB, Leng F, Przewloka T, Fokt I, Ling YH, Perez-Soler R, Priebe WJournal of medicinal chemistryStructure-based design of a new bisintercalating anthracycline antibiotic. J Med Chem. 1997 Jan 31; 40(3):261-6.J Med Chem1997-01-31T00:00:001997Structure-based design of a new bisintercalating anthracycline antibiotic.9443942Marbeuf-Gueye C, Broxterman HJ, Dubru F, Priebe W, Garnier-Suillerot AMolecular pharmacologyKinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells. Mol Pharmacol. 1998 Jan; 53(1):141-7.Mol Pharmacol1998-01-01T00:00:001998Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.11127949Booser DJ, Perez-Soler R, Cossum P, Esparza-Guerra L, Wu QP, Zou Y, Priebe W, Hortobagyi GNCancer chemotherapy and pharmacologyPhase I study of liposomal annamycin. Cancer Chemother Pharmacol. 2000; 46(5):427-32.Cancer Chemother Pharmacol2000-01-01T00:00:002000Phase I study of liposomal annamycin.11172689Taatjes DJ, Koch THCurrent medicinal chemistryNuclear targeting and retention of anthracycline antitumor drugs in sensitive and resistant tumor cells. Curr Med Chem. 2001 Jan; 8(1):15-29.Curr Med Chem2001-01-01T00:00:002001Nuclear targeting and retention of anthracycline antitumor drugs in sensitive and resistant tumor cells.11494869Priebe W, Fokt I, Przewloka T, Chaires JB, Portugal J, Trent JOMethods in enzymologyExploiting anthracycline scaffold for designing DNA-targeting agents. Methods Enzymol. 2001; 340:529-55.Methods Enzymol2001-01-01T00:00:002001Exploiting anthracycline scaffold for designing DNA-targeting agents.15182200Mansilla S, Priebe W, Portugal JBiochemistrySp1-targeted inhibition of gene transcription by WP631 in transfected lymphocytes. Biochemistry. 2004 Jun 15; 43(23):7584-92.Biochemistry2004-06-15T00:00:002004Sp1-targeted inhibition of gene transcription by WP631 in transfected lymphocytes.15253137Gruber BM, Anuszewska EL, Priebe WFolia histochemica et cytobiologicaThe effect of new anthracycline derivatives on the induction of apoptotic processes in human neoplastic cells. Folia Histochem Cytobiol. 2004; 42(2):127-30.Folia Histochem Cytobiol2004-01-01T00:00:002004The effect of new anthracycline derivatives on the induction of apoptotic processes in human neoplastic cells.15317591Fox KR, Webster R, Phelps RJ, Fokt I, Priebe WEuropean journal of biochemistrySequence selective binding of bis-daunorubicin WP631 to DNA. Eur J Biochem. 2004 Sep; 271(17):3556-66.Eur J Biochem2004-09-01T00:00:002004Sequence selective binding of bis-daunorubicin WP631 to DNA.15501458Inge TH, Harris NL, Wu J, Azizkhan RG, Priebe WThe Journal of surgical researchWP744 is a novel anthracycline with enhanced activity against neuroblastoma. J Surg Res. 2004 Oct; 121(2):187-96.J Surg Res2004-10-01T00:00:002004WP744 is a novel anthracycline with enhanced activity against neuroblastoma.16158963Gruber BM, Anuszewska EL, Bubko I, Gozdzik A, Priebe W, Fokt IAnticancer researchRelationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells. Anticancer Res. 2005 May-Jun; 25(3B):2193-8.Anticancer Res2005-05-01T00:00:002005Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells.17234779Tabe Y, Jin L, Tsutsumi-Ishii Y, Xu Y, McQueen T, Priebe W, Mills GB, Ohsaka A, Nagaoka I, Andreeff M, Konopleva MCancer researchActivation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res. 2007 Jan 15; 67(2):684-94.Cancer Res2007-01-15T00:00:002007Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.18159130Tamura A, Onishi Y, An R, Koshiba S, Wakabayashi K, Hoshijima K, Priebe W, Yoshida T, Kometani S, Matsubara T, Mikuriya K, Ishikawa TDrug metabolism and pharmacokineticsIn vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs. Drug Metab Pharmacokinet. 2007 Dec; 22(6):428-40.Drug Metab Pharmacokinet2007-12-01T00:00:002007In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs.19625015Fokt I, Szymanski S, Skora S, Cybulski M, Madden T, Priebe WCarbohydrate researchD-glucose- and D-mannose-based antimetabolites. Part 2. Facile synthesis of 2-deoxy-2-halo-D-glucoses and -D-mannoses. Carbohydr Res. 2009 Aug 17; 344(12):1464-73.Carbohydr Res2009-06-21T00:00:002009D-glucose- and D-mannose-based antimetabolites. Part 2. Facile synthesis of 2-deoxy-2-halo-D-glucoses and -D-mannoses.21183952Samanta A, Perazzona B, Chakraborty S, Sun X, Modi H, Bhatia R, Priebe W, Arlinghaus RLeukemiaJanus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia. Leukemia. 2011 Mar; 25(3):463-72.Leukemia2010-12-24T00:00:002010Janus kinase 2 regulates Bcr-Abl signaling in chronic myeloid leukemia.Authorship 2729743Authorship 2757502Authorship 2758052Authorship 27695432276153Horton D, Priebe W, Sznaidman MCarbohydrate researchIodoalkoxylation of 1,5-anhydro-2-deoxy-hex-1-enitols (glycals). Carbohydr Res. 1990 Sep 19; 205:71-86.Carbohydr Res1990-09-19T00:00:001990Iodoalkoxylation of 1,5-anhydro-2-deoxy-hex-1-enitols (glycals).2752388Horton D, Priebe W, Sznaidman MCarbohydrate researchPreparation of 4-O-acetyl-1,5-anhydro-2,3,6-trideoxy-3-trifluoroacetamido-L- lyxo-hex-1-enitol, a key intermediate in synthesis of daunosamine glycosides. Carbohydr Res. 1989 Apr 01; 187(1):145-8.Carbohydr Res1989-04-01T00:00:001989Preparation of 4-O-acetyl-1,5-anhydro-2,3,6-trideoxy-3-trifluoroacetamido-L- lyxo-hex-1-enitol, a key intermediate in synthesis of daunosamine glycosides.11248673Fr?zard F, Pereira-Maia E, Quidu P, Priebe W, Garnier-Suillerot AEuropean journal of biochemistryP-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine. Eur J Biochem. 2001 Mar; 268(6):1561-7.Eur J Biochem2001-03-01T00:00:002001P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine.15714127Maher JC, Savaraj N, Priebe W, Liu H, Lampidis TJPancreasDifferential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression. Pancreas. 2005 Mar; 30(2):e34-9.Pancreas2005-03-01T00:00:002005Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.Authorship 2788918Authorship 2789509Authorship 2849252Authorship 28598711Authorship 2898997Authorship 2952751Authorship 2995461Authorship 303476721573461Ling Y, Priebe W, Perezsoler RInternational journal of oncologyIntrinsic cytotoxicity and reversal of multidrug-resistance by monensin in kb parent and mdr cells. Int J Oncol. 1993 Nov; 3(5):971-7.Int J Oncol1993-11-01T00:00:001993Intrinsic cytotoxicity and reversal of multidrug-resistance by monensin in kb parent and mdr cells.22555804Swiatek-Machado K, Mieczkowski J, Ellert-Miklaszewska A, Swierk P, Fokt I, Szymanski S, Skora S, Szeja W, Grynkiewicz G, Lesyng B, Priebe W, Kaminska BCancer biology & therapyNovel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells. Cancer Biol Ther. 2012 Jun; 13(8):657-70.Cancer Biol Ther2012-06-01T00:00:002012Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.24804649Judd LM, Menheniott TR, Ling H, Jackson CB, Howlett M, Kalantzis A, Priebe W, Giraud ASPloS oneInhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo. PLoS One. 2014; 9(5):e95993.PLoS One2014-05-07T00:00:002014Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo.25689150Mansilla S, Vizca?no C, Rodr?guez-S?nchez MA, Priebe W, Portugal JJournal of cellular and molecular medicineAutophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cells. J Cell Mol Med. 2015 Apr; 19(4):786-98.J Cell Mol Med2015-02-16T00:00:002015Autophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cells.25966666Hossain A, Gumin J, Gao F, Figueroa J, Shinojima N, Takezaki T, Priebe W, Villarreal D, Kang SG, Joyce C, Sulman E, Wang Q, Marini FC, Andreeff M, Colman H, Lang FFStem cells (Dayton, Ohio)Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway. Stem Cells. 2015 Aug; 33(8):2400-15.Stem Cells2015-05-27T00:00:002015Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.26498188Priebe WGlycoconjugate journalObituary: Derek Horton (1933-2015). Glycoconj J. 2015 Nov; 32(8):557-8.Glycoconj J2015-11-01T00:00:002015Obituary: Derek Horton (1933-2015).74Professor10Assistant Professor54Instructor14Associate Professor26861698Shingu T, Holmes L, Henry V, Wang Q, Latha K, Gururaj AE, Gibson LA, Doucette T, Lang FF, Rao G, Yuan L, Sulman EP, Farrell NP, Priebe W, Hess KR, Wang YA, Hu J, B?gler OJournal of translational medicineSuppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells. J Transl Med. 2016 Feb 09; 14:46.J Transl Med2016-02-09T00:00:002016Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.18991807Heimberger AB, Priebe WRecent patents on CNS drug discoverySmall molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers. Recent Pat CNS Drug Discov. 2008 Nov; 3(3):179-88.Recent Pat CNS Drug Discov2008-11-01T00:00:002008Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers.20921210Kong LY, Wu AS, Doucette T, Wei J, Priebe W, Fuller GN, Qiao W, Sawaya R, Rao G, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchIntratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses. Clin Cancer Res. 2010 Dec 01; 16(23):5722-33.Clin Cancer Res2010-10-04T00:00:002010Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.21792892Hatiboglu MA, Kong LY, Wei J, Wang Y, McEnery KA, Fuller GN, Qiao W, Davies MA, Priebe W, Heimberger ABInternational journal of cancerThe tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models. Int J Cancer. 2012 Jul 01; 131(1):8-17.Int J Cancer2011-08-24T00:00:002011The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.22249692Sai K, Wang S, Balasubramaniyan V, Conrad C, Lang FF, Aldape K, Szymanski S, Fokt I, Dasgupta A, Madden T, Guan S, Chen Z, Alfred Yung WK, Priebe W, Colman HJournal of neuro-oncologyInduction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway. J Neurooncol. 2012 May; 107(3):487-501.J Neurooncol2012-01-17T00:00:002012Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway.17942891Hussain SF, Kong LY, Jordan J, Conrad C, Madden T, Fokt I, Priebe W, Heimberger ABCancer researchA novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. Cancer Res. 2007 Oct 15; 67(20):9630-6.Cancer Res2007-10-15T00:00:002007A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.19002459Kong LY, Wei J, Sharma AK, Barr J, Abou-Ghazal MK, Fokt I, Weinberg J, Rao G, Grimm E, Priebe W, Heimberger ABCancer immunology, immunotherapy : CIIA novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells. Cancer Immunol Immunother. 2009 Jul; 58(7):1023-32.Cancer Immunol Immunother2008-11-11T00:00:002008A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.19088040Abou-Ghazal M, Yang DS, Qiao W, Reina-Ortiz C, Wei J, Kong LY, Fuller GN, Hiraoka N, Priebe W, Sawaya R, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchThe incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas. Clin Cancer Res. 2008 Dec 15; 14(24):8228-35.Clin Cancer Res2008-12-15T00:00:002008The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.20053772Wei J, Barr J, Kong LY, Wang Y, Wu A, Sharma AK, Gumin J, Henry V, Colman H, Priebe W, Sawaya R, Lang FF, Heimberger ABMolecular cancer therapeuticsGlioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway. Mol Cancer Ther. 2010 Jan; 9(1):67-78.Mol Cancer Ther2010-01-06T00:00:002010Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.20214040Heimberger AB, Kong LY, Abou-Ghazal M, Reina-Ortiz C, Yang DS, Wei J, Qiao W, Schmittling RJ, Archer GE, Sampson JH, Hiraoka N, Priebe W, Fuller GN, Sawaya RClinical neurosurgeryThe role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor. Clin Neurosurg. 2009; 56:98-106.Clin Neurosurg2009-01-01T00:00:002009The role of tregs in human glioma patients and their inhibition with a novel STAT-3 inhibitor.20192118Kupferman ME, Jayakumar A, Zhou G, Xie T, Dakak-Yazici Y, Zhao M, Ju J, Mandal M, Jasser S, Madden T, Myers JN, Priebe WJournal of experimental therapeutics & oncologyTherapeutic suppression of constitutive and inducible JAK\STAT activation in head and neck squamous cell carcinoma. J Exp Ther Oncol. 2009; 8(2):117-27.J Exp Ther Oncol2009-01-01T00:00:002009Therapeutic suppression of constitutive and inducible JAK\STAT activation in head and neck squamous cell carcinoma.20199106He H, Nilsson CL, Emmett MR, Marshall AG, Kroes RA, Moskal JR, Ji Y, Colman H, Priebe W, Lang FF, Conrad CAJournal of proteome researchGlycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation. J Proteome Res. 2010 May 07; 9(5):2098-108.J Proteome Res2010-05-07T00:00:002010Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation.20667896Wu A, Wei J, Kong LY, Wang Y, Priebe W, Qiao W, Sawaya R, Heimberger ABNeuro-oncologyGlioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol. 2010 Nov; 12(11):1113-25.Neuro Oncol2010-07-28T00:00:002010Glioma cancer stem cells induce immunosuppressive macrophages/microglia.20388845Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, Hailemichael Y, Fokt I, Jayakumar A, Qiao W, Fuller GN, Overwijk WW, Priebe W, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchInhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model. Clin Cancer Res. 2010 May 01; 16(9):2550-61.Clin Cancer Res2010-04-13T00:00:002010Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.20606045Pham LV, Tamayo AT, Li C, Bornmann W, Priebe W, Ford RJMolecular cancer therapeuticsDegrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications. Mol Cancer Ther. 2010 Jul; 9(7):2026-36.Mol Cancer Ther2010-07-06T00:00:002010Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications.21855629Kapuria V, Levitzki A, Bornmann WG, Maxwell D, Priebe W, Sorenson RJ, Showalter HD, Talpaz M, Donato NJCellular signallingA novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination. Cell Signal. 2011 Dec; 23(12):2076-85.Cell Signal2011-08-09T00:00:002011A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination.22753228Doucette TA, Kong LY, Yang Y, Ferguson SD, Yang J, Wei J, Qiao W, Fuller GN, Bhat KP, Aldape K, Priebe W, B?gler O, Heimberger AB, Rao GNeuro-oncologySignal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma. Neuro Oncol. 2012 Sep; 14(9):1136-45.Neuro Oncol2012-06-29T00:00:002012Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.Authorship 841169Authorship 841313Authorship 842739Authorship 842978Authorship 843199Authorship 843265Authorship 843336Authorship 843559Authorship 844014Authorship 844679Authorship 845158Authorship 845278Authorship 846415Authorship 846872Authorship 847648Authorship 850123Authorship 850466Authorship 850503Authorship 851111Authorship 851158Authorship 851690Authorship 851712Authorship 852079Authorship 852580Authorship 854336Authorship 854347Authorship 854382Authorship 854906Authorship 856648Authorship 857032Authorship 857394Authorship 857441Authorship 857786Authorship 858267Authorship 858969Authorship 859285Authorship 859855Authorship 859910Authorship 859976Authorship 860842Authorship 861395Authorship 862173Authorship 863985Authorship 864097Authorship 865119Authorship 865945Authorship 866856OncotargetStat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells. Oncotarget. 6:10016-10029.Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cellsNowotworyNawiazanie polsko-amerykanskiej wspólpracy w dziedzinie badan translacyjnych w chorobach nowotworowych. Nowotwory. 62:491-492.Nawiazanie polsko-amerykanskiej wspólpracy w dziedzinie badan translacyjnych w chorobach nowotworowychPolish Journal of ChemistryNovel synthesis of anomeric peroxides and hydroperoxides. Polish Journal of Chemistry. 73:1917-1920.Novel synthesis of anomeric peroxides and hydroperoxidesTetrahedron Letters2-Deoxy-1-O-silylated-β-hexopyranoses. Useful glycosyl donors and synthetic intermediates. Tetrahedron Letters. 32:2079-2082.2-Deoxy-1-O-silylated-β-hexopyranoses. Useful glycosyl donors and synthetic intermediatesCarbohydrate ResearchSynthesis of antitumor-active (7S,9S)-4-demethoxy-7-O-(2,6-dideoxy-2-iodo-α-l-mannopyranosyl)adriamycinone. Carbohydrate Research. 130.Synthesis of antitumor-active (7S,9S)-4-demethoxy-7-O-(2,6-dideoxy-2-iodo-α-l-mannopyranosyl)adriamycinoneJournal of the American Chemical SocietyBase specific and regioselective chemical cross-linking of daunorubicin to DNA. Journal of the American Chemical Society. 118:4731-4738.Base specific and regioselective chemical cross-linking of daunorubicin to DNABiospectroscopyInteraction of doxorubicin and its derivatives with DNA. Biospectroscopy. 3:307-316.Interaction of doxorubicin and its derivatives with DNACarbohydrate ResearchSynthetic routes to higher-carbon sugars. Reaction of lactones with 2-lithio-,3-dithiane. Carbohydrate Research. 94:27-41.Synthetic routes to higher-carbon sugars. Reaction of lactones with 2-lithio-,3-dithianeJournal of Molecular StructureVibrational studies of Pt(II) and Pd(II) complexation by 3,4-diamino lyxo-hexopyranoside. Journal of Molecular Structure. 614:203-209.Vibrational studies of Pt(II) and Pd(II) complexation by 3,4-diamino lyxo-hexopyranosideJournal of the American Chemical SocietyBase specific and regioselective chemical cross-linking of daunorubicin to DNA. Journal of the American Chemical Society. 118.Base specific and regioselective chemical cross-linking of daunorubicin to DNAInternational Journal of OncologyIntrinsic cytotoxicity and reversal of multidrug-resistance by monensin in KB parent and MDR cells. International Journal of Oncology. 3:971-977.Intrinsic cytotoxicity and reversal of multidrug-resistance by monensin in KB parent and MDR cellsPlant Physiology and BiochemistryApples. Plant Physiology and Biochemistry. 84:169e188.ApplesDalton TransactionsPlatinum(II) and palladium(II) complexes with methyl 3,4-diamino-2,3,4,6- tetradeoxy-α-L-lyxo-hexopyranoside. Dalton Transactions. 2177-2183.Platinum(II) and palladium(II) complexes with methyl 3,4-diamino-2,3,4,6- tetradeoxy-α-L-lyxo-hexopyranosideBioorganic and Medicinal Chemistry LettersBioorganic and Medicinal Chemistry Letters. 5:1807-1812.Bioorganic and Medicinal Chemistry LettersJournal of Organic ChemistrySteric and conformational effects in the dehalogenation of 2-halo sugar derivatives with tributylstannane. Journal of Organic Chemistry. 58:1821-1826.Steric and conformational effects in the dehalogenation of 2-halo sugar derivatives with tributylstannaneBiochemistryParsing the free energy of anthracycline antibiotic binding to DNA. Biochemistry. 35.Parsing the free energy of anthracycline antibiotic binding to DNAPolish Journal of ChemistrySynthesis of 1-O-silylated 3-azido- and 3-N-trifluoroacetamido-2,3,6- trideoxy-L-arabino and L-lyxo-hexopyranoses, convenient glycosyl donors for preparation of anthracycline antibiotics and related DNA-binding agents. Polish Journal of Chemistry. 79:335-347.Synthesis of 1-O-silylated 3-azido- and 3-N-trifluoroacetamido-2,3,6- trideoxy-L-arabino and L-lyxo-hexopyranoses, convenient glycosyl donors for preparation of anthracycline antibiotics and related DNA-binding agentsMagnetic Resonance in ChemistryMagnetic Resonance in Chemistry. 25:161-165.Magnetic Resonance in ChemistryCancer Biology and TherapyNovel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent anti-tumor activity in glioma cells. Cancer Biology and Therapy. 13:658-671.Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent anti-tumor activity in glioma cellsCanadian Journal of Applied SpectroscopyThe comparison of the influence of ionic potential and electronegativity of selected metals and halogens on the electronic system of benzoic acid. Canadian Journal of Applied Spectroscopy. 41:144-149.The comparison of the influence of ionic potential and electronegativity of selected metals and halogens on the electronic system of benzoic acidFresenius' Journal of Analytical ChemistryThe influence of selected metals and halogens on the electronic system of benzoic acid. Fresenius' Journal of Analytical Chemistry. 355:750-752.The influence of selected metals and halogens on the electronic system of benzoic acidMagnetic Resonance in Chemistry<sup>13</sup>C NMR spectra of allosteric effectors of hemoglobin. Magnetic Resonance in Chemistry. 32:182-183.<sup>13</sup>C NMR spectra of allosteric effectors of hemoglobinMoleculesTargeting DNA with anthracyclines. Molecules. 5:299-301.Targeting DNA with anthracyclinesTetrahedron LettersA facile and selective oxidation of sulfides to sulfones. Tetrahedron Letters. 32:7353-7356.A facile and selective oxidation of sulfides to sulfonesPolish Journal of ChemistryA facile transformation of benzylated methyl glycosides to thioglycosides. Polish Journal of Chemistry. 70:1270-1273.A facile transformation of benzylated methyl glycosides to thioglycosidesJournal of Organic ChemistryHalogenation of 1,5-anhydrohex-1-enitols (glycals). Influence of the C-6 substituent. Journal of Organic Chemistry. 51:3479-3485.Halogenation of 1,5-anhydrohex-1-enitols (glycals). Influence of the C-6 substituentJournal of Molecular StructureVibrational study of alkaline metal nicotinates, benzoates and salicylates. Journal of Molecular Structure. 604:189-193.Vibrational study of alkaline metal nicotinates, benzoates and salicylatesJournal of Cellular and Molecular MedicineAutophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cells. Journal of Cellular and Molecular Medicine. 19:786-798.Autophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cellsJournal of Liposome ResearchThe use of liposomes as carriers of lipophilic anthracycline antibiotics. Journal of Liposome Research. 4:555-573.The use of liposomes as carriers of lipophilic anthracycline antibioticsCurrent Medicinal ChemistryCurrent medical chemistry. Current Medicinal Chemistry. 8.Current medical chemistryJournal of Translational MedicineSuppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells. Journal of Translational Medicine. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cellsMonatshefte für Chemie Chemical MonthlySynthesis of new 1-C-(2-furyl)-and 3-C-(2-furyl)-hexopyranosides and 3-C-(2-furyl)-daunorubicin analogs - Short communication. Monatshefte für Chemie Chemical Monthly. 122:419-423.Synthesis of new 1-C-(2-furyl)-and 3-C-(2-furyl)-hexopyranosides and 3-C-(2-furyl)-daunorubicin analogs - Short communicationCarbohydrate ResearchSynthesis of alkyl 4,6-di-o-acetyl-2,3-dideoxy-α-d-threo-hex-2- enopyranosides from 3,4,6-tri-o-acetyl-1,5-anhydro-2-deoxy- d-lyxo-hex-1-enitol (3,4,6-tri-o-acetyl-d-galactal). Carbohydrate Research. 68:33-41.Synthesis of alkyl 4,6-di-o-acetyl-2,3-dideoxy-α-d-threo-hex-2- enopyranosides from 3,4,6-tri-o-acetyl-1,5-anhydro-2-deoxy- d-lyxo-hex-1-enitol (3,4,6-tri-o-acetyl-d-galactal)Tetrahedron LettersOne step C-acylation of glycals and 2-deoxy-hexopyranoses at C-2. Tetrahedron Letters. 33:7681-7684.One step C-acylation of glycals and 2-deoxy-hexopyranoses at C-2TetrahedronConfiguration and conformation of methyl 2,3-anhydro-4-deoxy-pyranosides by <sup>1</sup>H and <sup>13</sup>C NMR spectra. Tetrahedron. 34:3325-3330.Configuration and conformation of methyl 2,3-anhydro-4-deoxy-pyranosides by <sup>1</sup>H and <sup>13</sup>C NMR spectraTetrahedronThe acid-catalysed reaction of thiols with alkyl 2,3-dideoxy-glyc-2-enopyranosides or glycals. Tetrahedron. 36:287-297.The acid-catalysed reaction of thiols with alkyl 2,3-dideoxy-glyc-2-enopyranosides or glycalsCurrent Pharmaceutical DesignMechanism of action-governed design of anthracycline antibiotics. Current Pharmaceutical Design. 1:51-68.Mechanism of action-governed design of anthracycline antibioticsCurrent Organic ChemistryEditorial. Current Organic Chemistry. 12:972.EditorialHeterocyclic CommunicationsNew synthesis of O- and S-glycosyl derivatives of 2-chloro-3-cyano-5-nitropyridine. Heterocyclic Communications. 7:317-322.New synthesis of O- and S-glycosyl derivatives of 2-chloro-3-cyano-5-nitropyridineTetrahedron LettersTetrahedron Letters. 32:3313-3316.Tetrahedron LettersJournal of the American Chemical SocietyDissection of the free energy of antheracycline antibiotic binding to DNA. Journal of the American Chemical Society. 115:5360-5364.Dissection of the free energy of antheracycline antibiotic binding to DNACrystal Growth and DesignBromine atom interactions in biologically active acrylamide derivatives. Crystal Growth and Design. 15:2632-2642.Bromine atom interactions in biologically active acrylamide derivativesJournal of Chromatography AEnantioselective high-performance liquid chromatography of chiral intermediates in the total synthesis of 4-demethoxydaunomycinone. Journal of Chromatography A. 830:191-195.Enantioselective high-performance liquid chromatography of chiral intermediates in the total synthesis of 4-demethoxydaunomycinonePolish Journal of ChemistrySynthesis of kedarosamine, a sugar portion of the chromoprotein antibiotic kedarcidine. Polish Journal of Chemistry. 73:1143-1152.Synthesis of kedarosamine, a sugar portion of the chromoprotein antibiotic kedarcidinePolish Journal of ChemistryChirality probing of chlorotetrabutyratodiruthenium(II,III) complexes with vic-amino alcohols by circular dichroism spectroscopy. Polish Journal of Chemistry. 79:387-399.Chirality probing of chlorotetrabutyratodiruthenium(II,III) complexes with vic-amino alcohols by circular dichroism spectroscopyPolish Journal of ChemistryNew strategies towards synthesis of doxorubicin analogs. Polish Journal of Chemistry. 79:349-359.New strategies towards synthesis of doxorubicin analogsStem CellsMesenchymal Stem Cells Isolated from Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway. Stem Cells. 33:2400-2415.Mesenchymal Stem Cells Isolated from Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway23359207Garnett J, Chumbalkar V, Vaillant B, Gururaj AE, Hill KS, Latha K, Yao J, Priebe W, Colman H, Elferink LA, Bogler ONeoplasia (New York, N.Y.)Regulation of HGF expression by ?EGFR-mediated c-Met activation in glioblastoma cells. Neoplasia. 2013 Jan; 15(1):73-84.Neoplasia2013-01-01T00:00:002013Regulation of HGF expression by ?EGFR-mediated c-Met activation in glioblastoma cells.17043651Iwamaru A, Szymanski S, Iwado E, Aoki H, Yokoyama T, Fokt I, Hess K, Conrad C, Madden T, Sawaya R, Kondo S, Priebe W, Kondo YOncogeneA novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene. 2007 Apr 12; 26(17):2435-44.Oncogene2006-10-16T00:00:002006A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.18794085Kong LY, Abou-Ghazal MK, Wei J, Chakraborty A, Sun W, Qiao W, Fuller GN, Fokt I, Grimm EA, Schmittling RJ, Archer GE, Sampson JH, Priebe W, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchA novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells. Clin Cancer Res. 2008 Sep 15; 14(18):5759-68.Clin Cancer Res2008-09-15T00:00:002008A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.19899826Nilsson CL, Dillon R, Devakumar A, Shi SD, Greig M, Rogers JC, Krastins B, Rosenblatt M, Kilmer G, Major M, Kaboord BJ, Sarracino D, Rezai T, Prakash A, Lopez M, Ji Y, Priebe W, Lang FF, Colman H, Conrad CAJournal of proteome researchQuantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells. J Proteome Res. 2010 Jan; 9(1):430-43.J Proteome Res2010-01-01T00:00:002010Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells.21283755Wei J, Wu A, Kong LY, Wang Y, Fuller G, Fokt I, Melillo G, Priebe W, Heimberger ABPloS oneHypoxia potentiates glioma-mediated immunosuppression. PLoS One. 2011 Jan 20; 6(1):e16195.PLoS One2011-01-20T00:00:002011Hypoxia potentiates glioma-mediated immunosuppression.21692052Sandulache VC, Ow TJ, Pickering CR, Frederick MJ, Zhou G, Fokt I, Davis-Malesevich M, Priebe W, Myers JNCancerGlucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer. 2011 Jul 01; 117(13):2926-38.Cancer2011-01-10T00:00:002011Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.Authorship 88955914D004317Chemicals & Drugs62030040.582518DoxorubicinD018943Chemicals & Drugs1453310.838357AnthracyclinesD050796Chemicals & Drugs38311200.601372STAT3 Transcription FactorAuthorship 9082797Authorship 91181818Authorship 9218156Authorship 92545824Authorship 9258689Authorship 9266516D003630Chemicals & Drugs943010.896789Daunorubicin25146330Mielecki M, Milner-Krawczyk M, Grzelak K, Mielecki D, Krzysko KA, Lesyng B, Priebe WCurrent cancer drug targetsAnalogs of cinnamic acid benzyl amide as nonclassical inhibitors of activated JAK2 kinase. Curr Cancer Drug Targets. 2014; 14(7):638-51.Curr Cancer Drug Targets2014-01-01T00:00:002014Analogs of cinnamic acid benzyl amide as nonclassical inhibitors of activated JAK2 kinase.27576731Lamhamedi-Cherradi SE, Menegaz BA, Ramamoorthy V, Vishwamitra D, Wang Y, Maywald RL, Buford AS, Fokt I, Skora S, Wang J, Naing A, Lazar AJ, Rohren EM, Daw NC, Subbiah V, Benjamin RS, Ratan R, Priebe W, Mikos AG, Amin HM, Ludwig JAJournal of the National Cancer InstituteIGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma. J Natl Cancer Inst. 2016 12; 108(12).J Natl Cancer Inst2016-08-30T00:00:002016IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma.27923328Santoro M, Menegaz BA, Lamhamedi-Cherradi SE, Molina ER, Wu D, Priebe W, Ludwig JA, Mikos AGTissue engineering. Part AModeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma. Tissue Eng Part A. 2017 01; 23(1-2):80-89.Tissue Eng Part A2017-01-01T00:00:002017Modeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma.28417283Olbryt M, Rusin A, Fokt I, Habryka A, Tudrej P, Student S, Sochanik A, Zielinski R, Priebe WInvestigational new drugsBis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulation. Invest New Drugs. 2017 Oct; 35(5):545-555.Invest New Drugs2017-04-17T00:00:002017Bis-anthracycline WP760 abrogates melanoma cell growth by transcription inhibition, p53 activation and IGF1R downregulation.28825042Sonawane P, Choi YA, Pandya H, Herpai DM, Fokt I, Priebe W, Debinski WCancer translational medicineNovel Molecular Multilevel Targeted Antitumor Agents. Cancer Transl Med. 2017 May-Jun; 3(3):69-79.Cancer Transl Med2017-06-08T00:00:002017Novel Molecular Multilevel Targeted Antitumor Agents.29923182Ferguson SD, Zheng S, Xiu J, Zhou S, Khasraw M, Brastianos PK, Kesari S, Hu J, Rudnick J, Salacz ME, Piccioni D, Huang S, Davies MA, Glitza IC, Heymach JV, Zhang J, Ibrahim NK, DeGroot JF, McCarty J, O'Brien BJ, Sawaya R, Verhaak RGW, Reddy SK, Priebe W, Gatalica Z, Spetzler D, Heimberger ABInternational journal of cancerProfiles of brain metastases: Prioritization of therapeutic targets. Int J Cancer. 2018 12 01; 143(11):3019-3026.Int J Cancer2018-10-09T00:00:002018Profiles of brain metastases: Prioritization of therapeutic targets.D000903Chemicals & Drugs3587260.749506Antibiotics, AntineoplasticNeurosurgeryAuthorship 953386531385757Michel KA, Zielinski R, Walker CM, Le Roux L, Priebe W, Bankson JA, Schellingerhout DRadiologyHyperpolarized Pyruvate MR Spectroscopy Depicts Glycolytic Inhibition in a Mouse Model of Glioma. Radiology. 2019 10; 293(1):168-173.Radiology2019-08-06T00:00:002019Hyperpolarized Pyruvate MR Spectroscopy Depicts Glycolytic Inhibition in a Mouse Model of Glioma.Authorship 988168532340173Sharma P, Roberts C, Herpai D, Fokt ID, Priebe W, Debinski WPharmaceuticals (Basel, Switzerland)Drug Conjugates for Targeting Eph Receptors in Glioblastoma. Pharmaceuticals (Basel). 2020 Apr 23; 13(4).Pharmaceuticals (Basel)2020-04-23T00:00:002020Drug Conjugates for Targeting Eph Receptors in Glioblastoma.Authorship 9930831232605912Ott M, Kassab C, Marisetty A, Hashimoto Y, Wei J, Zamler D, Leu JS, Tomaszowski KH, Sabbagh A, Fang D, Gupta P, Priebe W, Zielinski RJ, Burks JK, Long JP, Kong LY, Fuller GN, DeGroot J, Sulman EP, Heimberger ABClinical cancer research : an official journal of the American Association for Cancer ResearchRadiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy. Clin Cancer Res. 2020 09 15; 26(18):4983-4994.Clin Cancer Res2020-06-30T00:00:002020Radiation with STAT3 Blockade Triggers Dendritic Cell-T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy.Authorship 10056042733230295Lin YH, Satani N, Hammoudi N, Yan VC, Barekatain Y, Khadka S, Ackroyd JJ, Georgiou DK, Pham CD, Arthur K, Maxwell D, Peng Z, Leonard PG, Czako B, Pisaneschi F, Mandal P, Sun Y, Zielinski R, Pando SC, Wang X, Tran T, Xu Q, Wu Q, Jiang Y, Kang Z, Asara JM, Priebe W, Bornmann W, Marszalek JR, DePinho RA, Muller FLNature metabolismAn enolase inhibitor for the targeted treatment of ENO1-deleted cancers. Nat Metab. 2020 12; 2(12):1413-1426.Nat Metab2020-11-23T00:00:002020An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.Authorship 10071672733340032Lin YH, Satani N, Hammoudi N, Yan VC, Barekatain Y, Khadka S, Ackroyd JJ, Georgiou DK, Pham CD, Arthur K, Maxwell D, Peng Z, Leonard PG, Czako B, Pisaneschi F, Mandal P, Sun Y, Zielinski R, Pando SC, Wang X, Tran T, Xu Q, Wu Q, Jiang Y, Kang Z, Asara JM, Priebe W, Bornmann W, Marszalek JR, DePinho RA, Muller FLNature metabolismAuthor Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. Nat Metab. 2021 Jan; 3(1):122.Nat Metab2021-01-01T00:00:002021Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.Authorship 10173061133918425Ziemniak M, Zawadzka-Kazimierczuk A, Pawledzio S, Malinska M, Soltyka M, Trzybinski D, Kozminski W, Skora S, Zielinski R, Fokt I, Priebe W, Wozniak K, Pajak BInternational journal of molecular sciencesExperimental and Computational Studies on Structure and Energetic Properties of Halogen Derivatives of 2-Deoxy-D-Glucose. Int J Mol Sci. 2021 Apr 02; 22(7).Int J Mol Sci2021-04-02T00:00:002021Experimental and Computational Studies on Structure and Energetic Properties of Halogen Derivatives of 2-Deoxy-D-Glucose.Authorship 1017696533948587McDonald JT, Enguita FJ, Taylor D, Griffin RJ, Priebe W, Emmett MR, Sajadi MM, Harris AD, Clement J, Dybas JM, Aykin-Burns N, Guarnieri JW, Singh LN, Grabham P, Baylin SB, Yousey A, Pearson AN, Corry PM, Saravia-Butler A, Aunins TR, Sharma S, Nagpal P, Meydan C, Foox J, Mozsary C, Cerqueira B, Zaksas V, Singh U, Wurtele ES, Costes SV, Davanzo GG, Galeano D, Paccanaro A, Meinig SL, Hagan RS, Bowman NM, UNC COVID-19 Pathobiology Consortium, Wolfgang MC, Altinok S, Sapoval N, Treangen TJ, Moraes-Vieira PM, Vanderburg C, Wallace DC, Schisler J, Mason CE, Chatterjee A, Meller R, Beheshti AbioRxiv : the preprint server for biologyThe Great Deceiver: miR-2392's Hidden Role in Driving SARS-CoV-2 Infection. bioRxiv. 2021 Aug 18.bioRxiv2021-08-18T00:00:002021The Great Deceiver: miR-2392's Hidden Role in Driving SARS-CoV-2 Infection.Authorship 10183461033981979Rios Perez MV, Roife D, Dai B, Pratt M, Dobrowolski R, Kang Y, Li X, Augustine JJ, Zielinski R, Priebe W, Fleming JBSurgery open scienceAntineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models. Surg Open Sci. 2019 Oct; 1(2):56-63.Surg Open Sci2019-07-03T00:00:002019Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models.Authorship 103066212Authorship 1031235434578985Kalinowska M, Golebiewska E, Swiderski G, Meczynska-Wielgosz S, Lewandowska H, Pietryczuk A, Cudowski A, Astel A, Swislocka R, Samsonowicz M, Zlowodzka AB, Priebe W, Lewandowski WNutrientsPlant-Derived and Dietary Hydroxybenzoic Acids-A Comprehensive Study of Structural, Anti-/Pro-Oxidant, Lipophilic, Antimicrobial, and Cytotoxic Activity in MDA-MB-231 and MCF-7 Cell Lines. Nutrients. 2021 Sep 04; 13(9).Nutrients2021-09-04T00:00:002021Plant-Derived and Dietary Hydroxybenzoic Acids-A Comprehensive Study of Structural, Anti-/Pro-Oxidant, Lipophilic, Antimicrobial, and Cytotoxic Activity in MDA-MB-231 and MCF-7 Cell Lines.34624208McDonald JT, Enguita FJ, Taylor D, Griffin RJ, Priebe W, Emmett MR, Sajadi MM, Harris AD, Clement J, Dybas JM, Aykin-Burns N, Guarnieri JW, Singh LN, Grabham P, Baylin SB, Yousey A, Pearson AN, Corry PM, Saravia-Butler A, Aunins TR, Sharma S, Nagpal P, Meydan C, Foox J, Mozsary C, Cerqueira B, Zaksas V, Singh U, Wurtele ES, Costes SV, Davanzo GG, Galeano D, Paccanaro A, Meinig SL, Hagan RS, Bowman NM, UNC COVID-19 Pathobiology Consortium, Wolfgang MC, Altinok S, Sapoval N, Treangen TJ, Moraes-Vieira PM, Vanderburg C, Wallace DC, Schisler JC, Mason CE, Chatterjee A, Meller R, Beheshti ACell reportsRole of miR-2392 in driving SARS-CoV-2 infection. Cell Rep. 2021 10 19; 37(3):109839.Cell Rep2021-09-30T00:00:002021Role of miR-2392 in driving SARS-CoV-2 infection.Authorship 1035939834944565Pajak B, Siwiak-Niedbalska E, Jaskiewicz A, Soltyka M, Zielinski R, Domoradzki T, Fokt I, Sk?ra S, Priebe WBiomedicinesSynergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model. Biomedicines. 2021 Nov 23; 9(12).Biomedicines2021-11-23T00:00:002021Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model.Authorship 10413002135233572Guarnieri JW, Dybas JM, Fazelinia H, Kim MS, Frere J, Zhang Y, Albrecht YS, Murdock DG, Angelin A, Singh LN, Weiss SL, Best SM, Lott MT, Cope H, Zaksas V, Saravia-Butler A, Meydan C, Foox J, Mozsary C, Kidane YH, Priebe W, Emmett MR, Meller R, Singh U, Bram Y, tenOever BR, Heise MT, Moorman NJ, Madden EA, Taft-Benz SA, Anderson EJ, Sanders WA, Dickmander RJ, Baxter VK, Baylin SB, Wurtele ES, Moraes-Vieira PM, Taylor D, Mason CE, Schisler JC, Schwartz RE, Beheshti A, Wallace DCbioRxiv : the preprint server for biologyTARGETED DOWN REGULATION OF CORE MITOCHONDRIAL GENES DURING SARS-COV-2 INFECTION. bioRxiv. 2022 Feb 22.bioRxiv2022-02-22T00:00:002022TARGETED DOWN REGULATION OF CORE MITOCHONDRIAL GENES DURING SARS-COV-2 INFECTION.Authorship 10439459Authorship 1043974935424802Ziemniak M, Pawledzio S, Zawadzka-Kazmierczuk A, Dominiak PM, Trzybinski D, Kozminski W, Zielinski R, Fokt I, Priebe W, Wozniak K, Pajak BRSC advancesX-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution. RSC Adv. 2022 03 15; 12(14):8345-8360.RSC Adv2022-03-15T00:00:002022X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution.35427095Ziemniak M, Pawledzio S, Zawadzka-Kazimierczuk A, Dominiak PM, Trzybinski D, Kozminski W, Zielinski R, Fokt I, Priebe W, Wozniak K, Pajak BRSC advancesCorrection: X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution. RSC Adv. 2022 Mar 31; 12(17):10306.RSC Adv2022-03-31T00:00:002022Correction: X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-d-glucose in solid state and solution.16261846Nair RR, Wang H, Jamaluddin MS, Fokt I, Priebe W, Boyd DDOncology researchA bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region. Oncol Res. 2005; 15(5):265-79.Oncol Res2005-01-01T00:00:002005A bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region.Authorship 10460191735575067Groot J, Ott M, Wei J, Kassab C, Fang D, Najem H, O'Brien B, Weathers SP, Matsouka CK, Majd NK, Harrison RA, Fuller GN, Huse JT, Long JP, Sawaya R, Rao G, MacDonald TJ, Priebe W, DeCuypere M, Heimberger ABCNS oncologyA first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma. CNS Oncol. 2022 06 01; 11(2):CNS87.CNS Oncol2022-05-16T00:00:002022A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.Authorship 1060616836144664Pajak B, Zielinski R, Manning JT, Matejin S, Paessler S, Fokt I, Emmett MR, Priebe WMolecules (Basel, Switzerland)The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses. Molecules. 2022 Sep 12; 27(18).Molecules2022-09-12T00:00:002022The Antiviral Effects of 2-Deoxy-D-glucose (2-DG), a Dual D-Glucose and D-Mannose Mimetic, against SARS-CoV-2 and Other Highly Pathogenic Viruses.Authorship 1065813436926129Martinez-Castillo M, Altamirano-Mendoza I, Zielinski R, Priebe W, Pi?a-Barba C, Gutierrez-Reyes GWorld journal of clinical casesCollagen matrix scaffolds: Future perspectives for the management of chronic liver diseases. World J Clin Cases. 2023 Feb 26; 11(6):1224-1235.World J Clin Cases2023-02-26T00:00:002023Collagen matrix scaffolds: Future perspectives for the management of chronic liver diseases.Authorship 1066092436951632Hughes EA, Zielinski R, Ray AE, Priebe W, Douglass Junior EFChembiochem : a European journal of chemical biologyDevelopment of a Novel Tool To Demystify Drug Distribution at Tissue-Blood Barriers. Chembiochem. 2023 07 03; 24(13):e202200804.Chembiochem2023-06-01T00:00:002023Development of a Novel Tool To Demystify Drug Distribution at Tissue-Blood Barriers.Authorship 1066828636966697Dempke WCM, Zielinski R, Winkler C, Silberman S, Reuther S, Priebe WEuropean journal of cancer (Oxford, England : 1990)Anthracycline-induced cardiotoxicity - are we about to clear this hurdle? Eur J Cancer. 2023 05; 185:94-104.Eur J Cancer2023-02-24T00:00:002023Anthracycline-induced cardiotoxicity - are we about to clear this hurdle?Authorship 1072861837356236Fokt I, Cybulski M, Skora S, Pajak B, Ziemniak M, Wozniak K, Zielinski R, Priebe WCarbohydrate researchd-Glucose- and d-mannose-based antimetabolites. Part 4: Facile synthesis of mono- and di-acetates of 2-deoxy-d-glucose prodrugs as potentially useful antimetabolites. Carbohydr Res. 2023 Sep; 531:108861.Carbohydr Res2023-06-07T00:00:002023d-Glucose- and d-mannose-based antimetabolites. Part 4: Facile synthesis of mono- and di-acetates of 2-deoxy-d-glucose prodrugs as potentially useful antimetabolites.Authorship 10781922337556555Guarnieri JW, Dybas JM, Fazelinia H, Kim MS, Frere J, Zhang Y, Soto Albrecht Y, Murdock DG, Angelin A, Singh LN, Weiss SL, Best SM, Lott MT, Zhang S, Cope H, Zaksas V, Saravia-Butler A, Meydan C, Foox J, Mozsary C, Bram Y, Kidane Y, Priebe W, Emmett MR, Meller R, Demharter S, Stentoft-Hansen V, Salvatore M, Galeano D, Enguita FJ, Grabham P, Trovao NS, Singh U, Haltom J, Heise MT, Moorman NJ, Baxter VK, Madden EA, Taft-Benz SA, Anderson EJ, Sanders WA, Dickmander RJ, Baylin SB, Wurtele ES, Moraes-Vieira PM, Taylor D, Mason CE, Schisler JC, Schwartz RE, Beheshti A, Wallace DCScience translational medicineCore mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Sci Transl Med. 2023 08 09; 15(708):eabq1533.Sci Transl Med2023-08-09T00:00:002023Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts.true1ProfessorProfessortrue1InstructorInstructortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor